(BHF) Brighthouse Financial - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US10922N1037

BHF: Annuities, Life Insurance, Structured Settlements

Brighthouse Financial, Inc. (NASDAQ: BHF) is a U.S.-based financial services company specializing in annuity and life insurance products. Established in 1863, the firm has a long-standing presence in the insurance industry. Headquartered in Charlotte, North Carolina, Brighthouse operates through three distinct business segments: Annuities, Life, and Run-off.

The Annuities segment offers a range of products, including variable, fixed, index-linked, and income annuities. These products are designed to meet contract holders needs for tax-deferred wealth accumulation, wealth transfer, and income security. The Life segment provides term, universal, whole, and variable life insurance policies, catering to policyholders seeking financial security and protected wealth transfer solutions.

The Run-off segment is focused on managing legacy products, including structured settlements, pension risk transfer contracts, certain company-owned life insurance policies, funding agreements, and universal life policies with secondary guarantees. This segment is essentially winding down older, less core businesses, optimizing capital allocation, and reducing operational complexity.

Brighthouse Financial, Inc. is listed on the NASDAQ exchange under the ticker symbol BHF. As of recent data, the company has a market capitalization of approximately $3.44 billion. Its trailing P/E ratio stands at 12.04, with a forward P/E of 3.03, indicating expectations of significant earnings growth. The price-to-book (P/B) ratio is 0.69, suggesting the market values the company below its book value, while the price-to-sales (P/S) ratio of 0.71 reflects its valuation relative to revenue.

For investors and fund managers, Brighthouse Financials diversified product portfolio and focus on de-risking its balance sheet are key considerations. The companys ability to manage its run-off businesses while growing its core annuity and life insurance segments will be critical to its long-term profitability and shareholder value creation.

Additional Sources for BHF Stock

BHF Stock Overview

Market Cap in USD 3,366m
Sector Financial Services
Industry Insurance - Life
GiC Sub-Industry Life & Health Insurance
IPO / Inception 2017-07-17

BHF Stock Ratings

Growth 5y 66.1%
Fundamental 20.1%
Dividend 0.0%
Rel. Strength -5.75
Analysts 2.7/5
Fair Price Momentum 59.56 USD
Fair Price DCF -

BHF Dividends

No Dividends Paid

BHF Growth Ratios

Growth Correlation 3m 44%
Growth Correlation 12m 59.2%
Growth Correlation 5y 50.1%
CAGR 5y 23.25%
CAGR/Max DD 5y 0.66
Sharpe Ratio 12m 0.53
Alpha 4.82
Beta 1.118
Volatility 31.89%
Current Volume 918.6k
Average Volume 20d 713.9k
What is the price of BHF stocks?
As of April 01, 2025, the stock is trading at USD 57.99 with a total of 918,644 shares traded.
Over the past week, the price has changed by -2.28%, over one month by -2.23%, over three months by +20.71% and over the past year by +13.82%.
Is Brighthouse Financial a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Brighthouse Financial is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 20.08 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BHF as of April 2025 is 59.56. This means that BHF is currently overvalued and has a potential downside of 2.71%.
Is BHF a buy, sell or hold?
Brighthouse Financial has received a consensus analysts rating of 2.70. Therefor, it is recommend to hold BHF.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 6
  • Sell: 1
  • Strong Sell: 2
What are the forecast for BHF stock price target?
According to ValueRays Forecast Model, BHF Brighthouse Financial will be worth about 64.3 in April 2026. The stock is currently trading at 57.99. This means that the stock has a potential upside of +10.92%.
Issuer Forecast Upside
Wallstreet Target Price 64.3 10.9%
Analysts Target Price 52.4 -9.7%
ValueRay Target Price 64.3 10.9%